AD-211

AD-211 · Addpharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD-211, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Determining the Optimal Dose of AD-211 in Patients With Osteoarthritis of the Knee [Phase 2]